MI-219-zinc combination: a new paradigm in MDM2 inhibitor-based therapy.
Azmi AS, Philip PA, Beck FW, Wang Z, Banerjee S, Wang S, Yang D, Sarkar FH, Mohammad RM.
Azmi AS, et al. Among authors: wang z, wang s.
Oncogene. 2011 Jan 6;30(1):117-26. doi: 10.1038/onc.2010.403. Epub 2010 Sep 6.
Oncogene. 2011.
PMID: 20818437
Free PMC article.